TickerFacts.

Embecta Corp. (EMBC): Cost of Revenue

Annual figures by period end, from SEC filings.

$403.60M
Year ended 2025-09-30
$417.40M
Trailing 12 months to 2026-06-30
+4.4%
3-year compound annual growth
+4.6%
5-year compound annual growth
2020-09-30: $322.90M2021-09-30: $364.90M2022-09-30: $354.60M2023-09-30: $370.90M2024-09-30: $387.90M2025-09-30: $403.60M$403.60M
2020-09-30 Cost of Revenue (USD) 2025-09-30
Period endedCost of RevenueChange YoYSource filing
2025-09-30$403.60M+4.0%2025-11-25, From 2024-10-01
2024-09-30$387.90M+4.6%2025-11-25, From 2023-10-01
2023-09-30$370.90M+4.6%2025-11-25, From 2022-10-01
2022-09-30$354.60M-2.8%2024-12-11, From 2021-10-01
2021-09-30$364.90M+13.0%2023-11-29, From 2020-10-01
2020-09-30$322.90Mn/a2022-12-22, From 2019-10-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Embecta Corp. (EMBC)2025-09-30$403.60M+4.0%
Tandem Diabetes Care Inc (TNDM)2025-12-31$468.72M+4.0%
Inspire Medical Systems, Inc. (INSP)2025-12-31$133.22M+8.3%
Haemonetics Corp (HAE)2026-03-28$546.44M-10.7%
Penumbra Inc (PEN)2025-12-31$461.23M+4.9%
Orthofix Medical Inc. (OFIX)2025-12-31$256.30M+1.1%
Merit Medical Systems Inc (MMSI)2025-12-31$777.64M+9.0%
Alphatec Holdings, Inc. (ATEC)2025-12-31$232.27M+24.0%
iRhythm Holdings, Inc. (IRTC)2025-12-31$219.89M+19.3%

Compare EMBC, TNDM, INSP, HAE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗